Haoxi Health Technology Limited Extraordinary General Meeting

Haoxi Health Technology Limited is holding an extraordinary general meeting on June 2, 2026, to vote on several key proposals. The primary proposals include a significant increase in the company's authorized share capital, from US$384,250,000 to US$35,200,000,000,000. This increase is intended to provide greater flexibility for future equity financings, strategic investments, acquisitions, and employee incentive plans. Additionally, shareholders will vote on adopting the eighth amended and restated memorandum and articles of association to reflect this share capital increase and a change in the quorum requirements for shareholder meetings. Another crucial proposal is to authorize one or more share consolidations, with ratios ranging from 1-for-2 to 1-for-8,000, aimed at ensuring compliance with Nasdaq's minimum bid price rule and avoiding delisting. The company also proposes amending its articles of association to reflect any share consolidation and seeks authorization to adjourn the meeting if necessary to solicit further proxies. The Board of Directors unanimously recommends voting "FOR" all proposed resolutions, emphasizing the importance of these measures for the company's continued listing on Nasdaq and its future strategic flexibility. Shareholders of record as of May 21, 2026, are entitled to vote.